Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Position Cut by Wrapmanager Inc.

Wrapmanager Inc. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 671 shares of the medical equipment provider’s stock after selling 48 shares during the quarter. Wrapmanager Inc.’s holdings in Intuitive Surgical were worth $350,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Bennett Selby Investments LP lifted its holdings in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after purchasing an additional 17 shares in the last quarter. LVW Advisors LLC lifted its position in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. grew its holdings in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares during the last quarter. FSM Wealth Advisors LLC raised its holdings in Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after acquiring an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC lifted its holdings in shares of Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after buying an additional 19 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,240 shares of company stock valued at $3,529,040 in the last ninety days. 0.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several brokerages have recently weighed in on ISRG. Evercore ISI lifted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. CICC Research assumed coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Barclays increased their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Down 0.1 %

Shares of ISRG opened at $591.01 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The business’s 50 day moving average price is $566.43 and its 200-day moving average price is $526.49. The stock has a market cap of $210.51 billion, a P/E ratio of 92.20, a P/E/G ratio of 5.85 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.